Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.

Clinical trial NCT01806961 · TERMINATED

Trial details

NCT number: NCT01806961
Sponsor: Spirig Pharma Ltd.
Status: TERMINATED
Study type: OBSERVATIONAL

Actinic Keratosis

Start date: 2013-01-01
Primary completion: 2013-06-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.